相关实验视频
Updated: Mar 12, 2026

04:49
Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
1.2K
在同核素播种中五年疾病进展 阳性 散发性 帕金森病
Paulina Gonzalez-Latapi1, Caroline Gochanour2, Seung Ho Choi2
1The Ken and Ruth Davee Department of Neurology, Chicago, Illinois, USA.
Annals of clinical and translational neurology
|March 11, 2026
概括
同核素播种试验 (SAA) 阳性帕金森病 (PD) 患者表现出不同的进展. 基于生物和功能障碍的早期分期对于临床试验至关重要,而不仅仅是临床诊断.
科学领域:
- 神经学 神经学
- 神经退行性疾病 神经退行性疾病
- 生物标志物 生物标志物
背景情况:
- 偶发性帕金森病 (PD) 是异质的.
- 同核素播种试验 (SAA) 的阳性确定了早期PD患者的一个子集.
- 目前的临床分期可能无法完全捕捉疾病的异质性.
研究的目的:
- 用神经元同核蛋白疾病综合分期框架来描述SAA阳性零星PD的疾病进展.
- 评估生物和功能障碍分期用于预测临床里程碑的有用性.
主要方法:
- 对345名SAA阳性早期零星PD参与者的5年纵向数据的分析 (帕金森病进展标志物倡议).
- 使用考克斯比例危险模型评估临床和生物标志物进展.
- 对多巴胺转运体结合,CSF-SAA,粉样蛋白-β,,尿酸盐和神经纤维光链的评估.
主要成果:
- 基线分期 (阶段2b,3,4) 显示了进展率的显著差异.
- 第4阶段的参与者表现出更高的残疾率,姿势不稳定,认知衰退和自主功能障碍.
- 在基线或纵向阶段之间没有观察到液体生物标志物的显著差异.
结论:
- 早期帕金森病表现出显著的异质性,甚至在SAA阳性队列中.
- 转向生物和功能定义的标准对于未来的临床试验招生至关重要.
- 需要进一步的研究来探索这种观察到的异质性的生物驱动因素.
相关概念视频
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Neural Regulation
44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K

